GlassScriptPhysician profile
Heidi Jo Lindstad
NPI 1952890808
$2,184.41
in general payments reported to CMS, 2019-2025
17 companies · $334 in 2025
The $334 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $279 · 2024: $1,571 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,184.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $567.11 | 2023-2025 | Vumerity, Tysabri |
| Tg Therapeutics, INC. | $442.43 | 2024 | |
| Emd Serono, INC. | $435.66 | 2023-2024 | Mavenclad, Mavenclad |
| E.R. Squibb & Sons, L.L.C. | $125.00 | 2023 | Zeposia |
| Abbvie INC. | $118.26 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $105.23 | 2024 | Ponvory |
| Amgen INC. | $89.88 | 2025 | Uplizna |
| Pfizer INC. | $60.11 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $41.64 | 2024-2025 | Austedo Xr, Austedo Xr |
| Sk Life Science, INC. | $37.59 | 2024 | |
| Genentech USA, INC. | $35.70 | 2024 | Ocrevus, Ocrevus Zunovo |
| Argenx US, INC. | $31.48 | 2024 | Vyvgart Hytrulo, Vyvgart |
| Alexion Pharmaceuticals, INC. | $30.98 | 2024 | Ultomiris |
| Amneal Pharmaceuticals LLC | $18.03 | 2025 | Crexont |
| Celgene Corporation | $17.92 | 2025 | Zeposia |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.09 | 2023 | |
| Lilly USA, LLC | $13.30 | 2024 | Kisunla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Lindstad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.